Irazu Oncology

Mar 04 2025

Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities

By Irazu Oncology Press Release

Irazú Oncology, LLC, a biotechnology company developing next-generation cancer immunotherapies, today announced the closing of bridge financing and key organizational developments, including the appointment of a Chief Medical Officer and…

Feb 22 2024

Love0

RealLIST Startups 2024: Discover the 20 Baltimore Startups Shaping Tomorrow’s Entrepreneurial Landscape

https://technical.ly/startups/reallist-startups-baltimore-2024/

Dec 20 2023

Love0

Baltimore Money Moves: Biotech Wins Big (Again)

https://technical.ly/startups/baltimore-money-moves-biotech-cambium-carbon-manufacturing/

Dec 19 2023

Love0

USM Maryland Momentum Fund and University of Maryland, Baltimore Invest in Irazu Oncology

https://www.umbiopark.com/news-events/news/5513/usm-maryland-momentum-fund-and-university-maryland-baltimore-invest-irazu

Dec 19 2023

Love0

Irazú Oncology Secures $2.6M Seed Investment to Advance Innovative Cancer Vaccine Platform

https://wexfordscitech.com/irazu-secures-2-6m-investment-to-advance-innovative-cancer-vaccine-platform/

Dec 18 2023

Love0

Irazu Oncology Secures $2.6M Debt to Advance UMB’s Vaccine Technology

https://www.citybiz.co/article/500559/irazu-oncology-secures-2-6m-debt-to-advance-umbs-vaccine-technology/

Nov 07 2023

Love0

Irazú Oncology and University of Maryland, Baltimore Mark Anniversary of Exclusive License for Development of Colorectal Cancer Vaccine

https://www.umventures.org/news/iraz%C3%BA-oncology-and-university-maryland-baltimore-mark-anniversary-exclusive-license-development

Aug 28 2023

Love0

Irazu Oncology Receives Funding from TEDCO’s Maryland Innovation Initiative (MII) to Support Efforts to Develop and Commercialize its Vaccine Platform

https://www.tedcomd.com/mii-portfolio

Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities

RealLIST Startups 2024: Discover the 20 Baltimore Startups Shaping Tomorrow’s Entrepreneurial Landscape

Baltimore Money Moves: Biotech Wins Big (Again)

USM Maryland Momentum Fund and University of Maryland, Baltimore Invest in Irazu Oncology

Irazú Oncology Secures $2.6M Seed Investment to Advance Innovative Cancer Vaccine Platform

Irazu Oncology Secures $2.6M Debt to Advance UMB’s Vaccine Technology

Irazú Oncology and University of Maryland, Baltimore Mark Anniversary of Exclusive License for Development of Colorectal Cancer Vaccine

Irazu Oncology Receives Funding from TEDCO’s Maryland Innovation Initiative (MII) to Support Efforts to Develop and Commercialize its Vaccine Platform

About

Leadership

Pipeline

Newsroom

Subscribe

Contact